Ribociclib improves progression-free survival in Asian women with advanced breast cancer

(European Society for Medical Oncology) Ribociclib significantly improves progression-free survival in Asian women with advanced breast cancer, according to a sub-analysis of the MONALEESA-2 trial presented at the ESMO Asia 2016 Congress in Singapore.